All News #Library
Sciences
Adalimumab Biosimilar SB5 Effective in Behçet’s Syndrome-Related Uveitis and IBD
28 Jan 2022 //
CENTERFORBIOSIMILARS
Immunomedics Announces Q1Fiscal 2019 Results, Provides Corporate Update
07 Nov 2018 //
GLOBENEWSWIRE
Biosim pain hits Roche and is coming for AbbVie, J&J: report
25 Oct 2018 //
FIERCE PHARMA
Merck, Samsung Bioepis end development on copy of Sanofi`s Lantus
13 Oct 2018 //
BIOPHARMA DIVE

Market Place
Sourcing Support